Bonafide Review 2026: Which Products Have Real Clinical Evidence
Bonafide sells nine hormone-free menopause products and claims 40 or more clinical trials behind them. Technically true. Also doing a lot of work. Read the footnotes on their […]
Bonafide sells nine hormone-free menopause products and claims 40 or more clinical trials behind them. Technically true. Also doing a lot of work. Read the footnotes on their own trials page and the evidence splits sharply: one product rests on solid independent research, two on small but genuine trials, the rest on unpublished data.
Why Menopause Symptoms Are Hard to Treat Without Hormones
- Estrogen decline drives most symptoms
- Hormone therapy works best and is not available to everyone
- Non-hormonal products compete under a lower ceiling
Falling estrogen causes hot flashes, vaginal tissue thinning, mood swings, and disrupted sleep. Hormone therapy replaces it. For women with estrogen-sensitive cancer history, clotting risk, or a preference against hormones, that route is closed. Bonafide sells into that gap.
Check the Best Bonafide Products Here
What Actually Helps Without Hormones
- Vaginal moisturizers act on tissue directly
- A few botanicals have real trials, most do not
- Guideline-backed options exist and are usually insured
The 2023 nonhormone therapy position statement from The North American Menopause Society recommends cognitive behavioral therapy, hypnosis, SSRIs, gabapentin, and fezolinetant for hot flashes. It places supplements and herbal remedies in the not-recommended column at evidence levels I to II.
Head-to-Head Comparison
| Product | Key Ingredient | Best Evidence | Quality | Best Fit |
|---|---|---|---|---|
| Revaree | Hyaluronic acid | Independent meta-analyses | Strong | Vaginal dryness |
| Noctera | Sleep blend | RCT, 127 women, 3 weeks | Moderate | Sleep |
| Clairvee | Lactobacillus | RCT, 40 patients | Moderate | Vaginal odor |
| Serenol | Flower pollen | RCT crossover, 2002 | Dated | Mood swings |
| Thermella | Curcumin blend | Unpublished analysis | Weak | Hot flashes |
5 Bonafide Products Ranked by Evidence
Revaree
Revaree is a hyaluronic acid vaginal insert, not a supplement. Bonafide calls it a personal lubricant, a different regulatory category and the one with the best published data.
A 2021 systematic review in The Journal of Sexual Medicine pooled five studies covering 335 women and found no significant difference between hyaluronic acid and vaginal estrogen on atrophy, vaginal pH, painful sex, or cell maturation. A 2026 meta-analysis in the International Journal of Gynecology and Obstetrics agreed.
That research is about hyaluronic acid, not Revaree. Bonafide’s own headline citation is a 2022 satisfaction survey whose lead author is also their Chief Medical Officer. Revaree does not need it.
Best For: Vaginal dryness when vaginal estrogen is unwanted.
Noctera
Noctera has the largest well-designed study on Bonafide’s page: a randomized, double-blind, placebo-controlled trial in 127 women reporting roughly 40 minutes more sleep.
Real design, real sample size. The limitation is duration. It ran three weeks. Menopausal sleep disruption runs for years, and nothing here tells you what month six looks like.
Best For: Short-term sleep support, with no long-term data.
Clairvee
Clairvee pairs two Lactobacillus strains with lactoferrin and folate. Its best citation is a 2019 randomized, double-blind, placebo-controlled trial in Beneficial Microbes covering 40 patients without a diagnosed infection.
Forty is small, but the design is sound. The dramatic marketing figures, 74 percent odor reduction at two weeks and 100 percent at six months, come from a separate open-label study listed as data on file. Two different tiers of evidence, one chart.
Best For: Mild odor with no infection. Persistent symptoms need testing.
Serenol
Serenol uses Swedish flower pollen for mood swings. The core citation is a randomized, double-blind, placebo-controlled crossover trial by Winther and colleagues.
The design is legitimate. The problems are age and population. It was published in 2002 and studied PMS, not menopause. The supporting figure, 82 percent planning to continue, comes from a survey of 290 customers who paid a $10 gift card.
Best For: Buyers comfortable with one dated trial in another population.
Thermella
Thermella is the most promoted product and the weakest on evidence. The headline numbers, 82 percent fewer hot flashes at two weeks rising to 97 percent at three months, carry a footnote reading “data on file based on a pooled analysis.” Data on file means unpublished.
A percentage of women reporting fewer hot flashes is a responder rate, not a measure of how much better anyone got. Hot flash trials routinely show placebo responses of 20 to 50 percent. Bonafide also claims the blend blocks neurokinin B, the target of the drug fezolinetant, without offering a study showing it does.
Best For: Discuss guideline-backed hot flash options with a clinician first.
Why the Footnote Matters for Bonafide
At the bottom of Bonafide’s clinical trials page: trials were run on Bonafide products or a key ingredient contained within them. That sentence explains the distance between “40 or more clinical trials” and what the page shows. It is disclosed, which beats most brands. But nobody scanning the headline reaches the same conclusion as someone reading the fine print.
Pros and Cons
| Pros | Cons |
|---|---|
| More testing than most brands | Evidence quality varies by product |
| ISO-accredited lot testing | Key hot flash data unpublished |
| No systemic hormone exposure | Surveys shown beside randomized trials |
| HSA and FSA eligible | Bundles reach $221 monthly |
How to Approach Bonafide: Step-by-Step
Step 1: Name your most disruptive symptom. Do not start with a bundle.
Step 2: Check whether a guideline-backed option exists. For hot flashes it does, and it is usually insured.
Step 3: Start with one product and give it the stated window, usually eight to twelve weeks.
Step 4: Check HSA and FSA eligibility before paying retail.
Step 5: Set a reminder to reassess. Subscriptions renew whether or not the product works.
How We Assessed These Products
We traced every study Bonafide cites back to its design, sample size, and publication status, then checked key ingredients against independent literature. Published randomized trials weighted highest, open-label studies and surveys lowest, unpublished data treated as unverifiable.
Ristela and Silvessa did not make the list. Ristela’s most-quoted figure comes from a 40-person open-label conference abstract, and one of its three cited studies had no placebo arm.
FAQs
Does Bonafide actually work?
Depends on the product. Revaree has strong independent evidence. Thermella’s key data is unpublished.
Is Bonafide better than hormone therapy?
No. Hormone therapy remains the most effective treatment for hot flashes.
Are Bonafide products safe?
Safety records are good. Revaree is not compatible with latex condoms, and Silvessa’s biotin interferes with lab tests.
What does “40+ clinical trials” mean?
Their own footnote says trials were run on products or on an ingredient within them, so the count includes research Bonafide did not conduct.
Medical disclaimer: Educational purposes only. Not medical advice. Talk to your provider before starting any supplement.
Final Verdict
Revaree: Excellent Choice. The hyaluronic acid literature is independent, consistent, and favorable.
Noctera and Clairvee: Situationally Useful. Genuine randomized trials, limited by small samples or short duration.
Serenol: Unproven for Menopause. One good trial from 2002, in PMS.
Thermella and Ristela: Not Recommended at the Price. You are buying against a guideline that says supplements do not work for hot flashes, on trials you cannot read.
Bonafide is better than most of this category. It just spends the credibility of one well-evidenced ingredient across eight products that have not earned it.